Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Never miss an Options trading signal: Unusual Options Activity and Options Screeners with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Evotec Se (EVO)

Evotec Se (EVO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Evotec Se ESSENER BOGEN 7 HAMBURG 2M 22419 DEU

www.evotec.com Employees: 4,827 P: 49-4056-0810 F: 405-608-1222

Sector:

Medical

Description:

EVOTEC is a leader in the discovery and development of novel small molecule drugs. They have established a powerful platform that is applicable to targets across all therapeutic areas and has specific expertise in the area of Central Nervous System related diseases where it is building a pipeline of drug candidates for partnering. Through research collaborations and proprietary projects They are providing the highest quality research results to its partners in the pharmaceutical and biotechnology industries

Key Statistics

Overview:

Market Capitalization, $K 1,107,934
Enterprise Value, $K 1,201,384
Shares Outstanding, K 355,107
Annual Sales, $ 862,400 K
Annual Net Income, $ -212,180 K
Last Quarter Sales, $ 191,570 K
Last Quarter Net Income, $ -50,360 K
EBIT, $ -97,300 K
EBITDA, $ 12,660 K
60-Month Beta 1.82
% of Insider Shareholders 1.00%
% of Institutional Shareholders 5.81%
Float, K 351,556
% Float 99.00%
Short Volume Ratio 0.77

Growth:

1-Year Return -34.71%
3-Year Return -62.89%
5-Year Return -80.26%
5-Year Revenue Growth 72.48%
5-Year Earnings Growth -100.00%
5-Year Dividend Growth 0.00%

Per-Share Information:

Next Earnings Date N/A
Earnings Per Share ttm 0.00
EPS Growth vs. Prev Qtr 0.00%
Annual Dividend & Yield 0.00 (0.00%)
Annual Dividend & Yield (Fwd) 0.00 (0.00%)
Dividend Payable Date 02/19/15
Dividend Payout Ratio 0.00%
Most Recent Split 4-1 on 10/20/21

EVO Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -18.20%
Return-on-Assets % -8.58%
Profit Margin % -24.60%
Debt/Equity 0.48
Price/Sales 1.33
Price/Cash Flow N/A
Price/Book 1.23
Book Value/Share 2.63
Interest Coverage -0.06
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar